Ethical Norms of Medical Research Essay -- Pharmaceutical Industry, Br

Branding, according to Parry, is to create a new thinking of the product to customers in the unique way so that the product can compete to others. And, in the pharmaceutical industry, branding is not only creating the new thinking of product, but also defining the best treatment for particular condition. If done so, the condition branding has numerous benefits because it creates consensus internally and externally. Internal consensus which is the activities focus on the problem and solution between brand managers and clinic so that the product can be maximized investment. Beside that, external consensus creates the better relationship between the owner and the clinical community to approach therapeutics (1). However, Fishman argued that branding leads to good sales and profits because the clinical trial researchers are position themselves as mediator between producers, pharmaceutical companies, and consumer, that are clinicians and patients, and they act like experts in that field. Therefore, the researchers create faithfulness to consumer, and in turn branding increase sales (12). As a mediator, researchers involve in the benefit of branding. Somehow, there is a conflict in their role between their benefit and the ethical norm of medical research. Fishman may be right when she implied that the ethical norm of medical research is driven by marketable drugs and marketable diagnoses. Let take a look in the process of how the drugs develop and bring to the market. First of all, the drug which is developed should meet the condition that can treat for disease with certain amount of patients, and then academic medical researchers are person who collect the clinical data, will mediate with FDA to get approval guideline for new drugs; ... ...cluded that With the increasing public†private arrangements being brokered between industry and academia, these ethical issues only become more entangled. Conventional medical ethics is unequipped to deal with these questions. Business ethics is likewise unable to accommodate the particular responsibilities of the biomedical project. The chasm left in between is where the academic researcher now treads, guided only by professional conventions and a growing entrepreneurialism and commercialism in medicine.(24). It may be strict if we say that the drugs market now needs to be control seriously and let the scientist be independent with their research because when drugs consider as other commodity, then patient become as customer not a patient. The patients need to be treated with medical ethical norm so that they can feel they are in treatment with good condition.